BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 119455
Published online Sep 19, 2026. doi: 10.5498/wjp.119455
Table 1 Baseline data comparison (nonunion vs healing), n (%)
Indicators
Nonunion group (n = 17)
Healing group (n = 128)
t/χ2
P value
Age (years)58.24 ± 11.1446.29 ± 14.763.2130.002
Gender 0.0240.878
Male12 (70.59)88 (68.75)
Female5 (29.41)40 (31.25)
Body mass index (kg/m2)25.19 ± 4.1023.70 ± 2.805.993< 0.001
Comorbidity
Hypertension8 (47.06)55 (42.97)0.1020.749
Diabetes7 (41.18)21 (16.41)5.9090.015
Atherosclerosis5 (29.41)20 (15.63)1.9990.157
Open fracture10 (58.8)28 (21.9)10.5900.001
Bone defect length (mm)51.82 ± 14.4338.44 ± 12.017.362< 0.001
Distraction start time (days)12.59 ± 5.8110.20 ± 3.492.4200.017
Distraction period (days)45.24 ± 10.6542.78 ± 9.720.9680.335
Bone mineralization time (days)275.18 ± 102.43191.45 ± 87.243.6390.004
Depression (PHQ-9)16.82 ± 4.2511.28 ± 3.1011.374< 0.001
Anxiety (GAD-7)15.24 ± 4.1210.51 ± 2.406.908< 0.001
Social support (MSPSS)48.53 ± 9.9858.83 ± 10.533.810< 0.001
Current smoker9 (52.9)35 (27.3)4.6520.031
Low-income11 (64.7)48 (37.5)4.6030.032
Table 2 Baseline data comparison in the external validation cohort (nonunion vs healing), n (%)
Indicators
Nonunion group (n = 10)
Healing group (n = 43)
t/χ2
P value
Age (years)55.80 ± 15.0247.78 ± 13.571.6540.104
Gender0.0240.876
Male7 (70.00)30 (69.77)
Female3 (30.00)13 (33.23)
Body mass index (kg/m2)25.75 ± 3.2124.79 ± 3.120.8670.390
Comorbidity
Hypertension5 (50.00)18 (69.57)0.2190.640
Diabetes4 (40.00)8 (18.60)2.1200.145
Atherosclerosis3 (30.00)7 (16.28)0.9980.318
Open fracture 6 (60.00)9 (20.93)6.1030.014
Bone defect length (mm)46.90 ± 14.1140.77 ± 12.761.3420.185
Distraction start time (days)10.20 ± 2.829.35 ± 3.310.7510.456
Distraction period (days)44.80 ± 9.6843.35 ± 8.750.4630.645
Bone mineralization time (days)197.10 ± 110.76211.05 ± 91.300.4180.678
Depression (PHQ-9)16.50 ± 4.1214.60 ± 3.021.6640.102
Anxiety (GAD-7)15.00 ± 3.7412.70 ± 2.412.4380.018
Social support (MSPSS)49.20 ± 9.2062.86 ± 10.073.922< 0.001
Current smoker5 (50.00)11 (25.58)2.4420.118
Low-income6 (60.00)17 (39.54)1.3830.239
Table 3 Baseline data comparison (development vs external validation), n (%)

Development cohort (n = 145)
External validation cohort (n = 53)
t/χ2
P value
Nonunion17 (11.72)10 (18.87)1.6820.195
Age (years)47.69 ± 14.8649.28 ± 14.060.6770.499
Gender0.0130.909
Male100 (68.97)37 (69.81)
Female45 (31.03)16 (30.19)
Body mass index (kg/m2)23.87 ± 3.0024.97 ± 3.132.2480.026
Bone defect length (mm)40.01 ± 13.0041.92 ± 13.110.9170.360
Distraction start time (days)10.48 ± 3.889.51 ± 3.211.6320.104
Distraction period (days)43.07 ± 9.8243.62 ± 8.860.3600.719
Bone mineralization time (days)201.26 ± 92.78208.42 ± 94.270.4790.633
Open fracture38 (26.21)15 (28.30)0.0870.768
Comorbidity
Hypertension63 (43.45)23 (43.40)0.0070.995
Diabetes28 (19.31)12 (22.64)0.2670.605
Atherosclerosis25 (17.24)10 (18.87)0.0710.791
Depression (PHQ-9)11.93 ± 3.7014.96 ± 3.305.2490.000
Anxiety (GAD-7)11.06 ± 3.9513.13 ± 2.814.3130.000
Social support (MSPSS)57.62 ± 10.9560.28 ± 11.211.5050.134
Current smoker44 (30.34)16 (30.19)0.0800.983
Low-income earner59 (40.69)23 (43.40)0.1170.732
Table 4 Summary of internal validation model performance indicators for the development cohort

Traditional clinical model
Integrated model
AUC (95%CI)0.854 (0.788-0.919)0.923 (0.856-0.990)
Sensitivity0.5880.882
Specificity0.8830.891
Accuracy0.8490.890
F1 score0.4760.640
DeLong’s test-P < 0.05
Table 5 Summary of model performance indicators for the external validation cohort

Traditional clinical model
Integrated model
AUC (95%CI)0.823 (0.692-0.954)0.888 (0.764-1.000)
Sensitivity0.2000.400
Specificity0.8840.978
Accuracy0.7500.867
F1 score0.2350.533
DeLong’s test-P < 0.05


Write to the Help Desk